HERC Short Courses in Health Economics
HERC currently offers two courses in health economics for external participants. Places are available on the one day 'Introduction to Health Economic Evaluation' course taking place in October 2018 and the three day 'Applied Methods of Cost-Effectiveness Analysis' course taking place in December 2018.
Read more
The Nuffield Department of Population Health has a full-time three year DPhil programme intended to train new researchers in Population Health.
Read more
Genomic Technology
HERC is involved in analysing the economic implications in several studies in the area of genomic technologies. These studies span numerous disease areas including cancers, cardiovascular disease and infectious diseases within hospitals and use a range of health economics tools, especially micro-costing, modelling and discrete choice experiments
Read moreHERC Newsletter - Issue 24 OUT NOW!
The August 2018 edition of the HERC newsletter is now available (click image to download)
Read more
Research
Our purpose is to contribute through our research to health and healthcare in the UK and internationally. We examine the economic aspects of health and disease, the costs and benefits of prevention and treatment, and the design and evaluation of health systems. Of particular importance in all areas is the rigour and innovativeness of the research methods we use.
Read moreThe Health Economics Research Centre (HERC)
HERC was established by the University of Oxford in 1996. Our aim is to contribute to health and healthcare in the UK and internationally, by conducting research on economic aspects of health and disease, the costs and benefits of prevention and treatment, and the design and evaluation of health systems.
Latest publications
-
Authors' Reply.
Herrington WG. et al, (2018), J Am Soc Nephrol
-
Towards incentivising integration: A typology of payments for integrated care
Stokes J. et al, (2018), Health Policy
-
The melanoma genomics managing your risk study: A protocol for a randomized controlled trial evaluating the impact of personal genomic risk information on skin cancer prevention behaviors.
Smit AK. et al, (2018), Contemp Clin Trials, 70, 106 - 116
-
Longitudinal medical resources and costs among type 2 diabetes patients participating in the Trial Evaluating Cardiovascular Outcomes with Sitagliptin (TECOS).
Reed SD. et al, (2018), Diabetes Obes Metab, 20, 1732 - 1739
-
Preference-based measures to obtain health state utility values for use in economic evaluations with child-based populations: a review and UK-based focus group assessment of patient and parent choices.
Wolstenholme JL. et al, (2018), Qual Life Res, 27, 1769 - 1780
-
Comparison of statistical approaches for analyzing incomplete longitudinal patient-reported outcome data in randomized controlled trials
Rombach I. et al, (2018), Patient Related Outcome Measures
-
Strengthening the evidence-base of integrated care for people with multi-morbidity in Europe using Multi-Criteria Decision Analysis (MCDA)
Rutten-van Molken M. et al, (2018), BMC Health Services Research
Latest news
-
HERC Newsletter - Issue 24 OUT NOW!
16 August 2018
Forthcoming HERC Courses
Introduction to Health Economic Evaluation
- 18 OCTOBER 2018, Oxford NEW DATE AVAILABLE: Booking now open.
- 19 OCTOBER 2018, Oxford. Limited availability
Applied Methods of Cost-Effectiveness Analysis
- 5-7th DECEMBER 2018, Oxford. Course Fully Booked 15/08/18 - Please submit a form to be registered on the waiting list
Founded in 1996
30+ Researchers
Over 1000 course participants
4000+ followers on social media
Forthcoming HERC Seminars
-
Title to be confirmed
Dr John Buckell, Postdoctoral Associate, Health Policy and Management, Yale School of Public Health
Monday, 10 September 2018, 1.30pm to 2.30pm